Compare CWAN & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CWAN | MASI |
|---|---|---|
| Founded | 2004 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 7.0B |
| IPO Year | 2021 | 2000 |
| Metric | CWAN | MASI |
|---|---|---|
| Price | $23.45 | $175.50 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 6 |
| Target Price | $25.09 | ★ $184.25 |
| AVG Volume (30 Days) | ★ 7.4M | 2.1M |
| Earning Date | 05-21-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 51.05 |
| EPS | ★ N/A | N/A |
| Revenue | $731,368,000.00 | ★ $1,239,153,000.00 |
| Revenue This Year | $31.86 | $8.59 |
| Revenue Next Year | $18.11 | $7.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 61.88 | 8.34 |
| 52 Week Low | $15.74 | $125.94 |
| 52 Week High | $28.37 | $175.90 |
| Indicator | CWAN | MASI |
|---|---|---|
| Relative Strength Index (RSI) | 48.20 | 75.53 |
| Support Level | $23.22 | $136.90 |
| Resistance Level | $24.33 | N/A |
| Average True Range (ATR) | 0.23 | 0.52 |
| MACD | 0.02 | 0.20 |
| Stochastic Oscillator | 79.05 | 73.86 |
Clearwater Analytics describes its mission as aiming to be the world's most trusted and comprehensive technology platform for the entire investment cycle. Clearwater has historically focused on back-office functions such as investment accounting, but with acquisitions such Enfusion, Beacon, and Bistro, the firm has broadened its focus with front-office and middle-office capabilities. Clearwater primarily serves insurance companies, asset managers, hedge funds, and corporate treasuries. Pro forma for Enfusion, about 76% of Clearwater's revenue is generated in the US.
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.